Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients.

Linhares UC, Schiavoni PB, Barros PO, Kasahara TM, Teixeira B, Ferreira TB, Alvarenga R, Hygino J, Vieira MM, Bittencourt VC, Andrade RM, Andrade AF, Bento CA.

J Clin Immunol. 2013 Jan;33(1):179-89. doi: 10.1007/s10875-012-9780-2. Epub 2012 Sep 5.

PMID:
22948743
2.

High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels.

Barros PO, Linhares UC, Teixeira B, Kasahara TM, Ferreira TB, Alvarenga R, Hygino J, Silva-Filho RG, Bittencourt VC, Andrade RM, Andrade AF, Bento CA.

Hum Immunol. 2013 Sep;74(9):1080-7. doi: 10.1016/j.humimm.2013.06.016. Epub 2013 Jun 15.

PMID:
23777933
3.

IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.

Xu W, Li R, Dai Y, Wu A, Wang H, Cheng C, Qiu W, Lu Z, Zhong X, Shu Y, Kermode AG, Hu X.

J Neuroimmunol. 2013 Aug 15;261(1-2):87-91. doi: 10.1016/j.jneuroim.2013.04.021. Epub 2013 May 28.

PMID:
23726764
4.

Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.

Barros PO, Cassano T, Hygino J, Ferreira TB, Centurião N, Kasahara TM, Andrade RM, Linhares UC, Andrade AF, Vasconcelos CC, Alvarenga R, Marignier R, Bento CA.

Clin Exp Immunol. 2016 Mar;183(3):480-9. doi: 10.1111/cei.12733. Epub 2015 Dec 1.

5.

Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

Wang HH, Dai YQ, Qiu W, Lu ZQ, Peng FH, Wang YG, Bao J, Li Y, Hu XQ.

J Clin Neurosci. 2011 Oct;18(10):1313-7. doi: 10.1016/j.jocn.2011.01.031. Epub 2011 Jul 26.

PMID:
21795048
6.

Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica.

Matsuya N, Komori M, Nomura K, Nakane S, Fukudome T, Goto H, Shiraishi H, Wandinger KP, Matsuo H, Kondo T.

Int Immunol. 2011 Sep;23(9):565-73. doi: 10.1093/intimm/dxr056. Epub 2011 Jul 27.

PMID:
21795759
7.

Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.

Içöz S, Tüzün E, Kürtüncü M, Durmuş H, Mutlu M, Eraksoy M, Akman-Demir G.

Int J Neurosci. 2010 Jan;120(1):71-5. doi: 10.3109/00207450903428970.

PMID:
20128675
8.

Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.

Yanagawa K, Kawachi I, Toyoshima Y, Yokoseki A, Arakawa M, Hasegawa A, Ito T, Kojima N, Koike R, Tanaka K, Kosaka T, Tan CF, Kakita A, Okamoto K, Tsujita M, Sakimura K, Takahashi H, Nishizawa M.

Neurology. 2009 Nov 17;73(20):1628-37. doi: 10.1212/WNL.0b013e3181c1deb9.

PMID:
19917985
9.

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.

Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, Cavillon G, Rogemond V, Confavreux C, Honnorat J, Giraudon P.

Brain. 2010 Sep;133(9):2578-91. doi: 10.1093/brain/awq177. Epub 2010 Aug 5.

PMID:
20688809
11.

Increased plasma interleukin-32 expression in patients with neuromyelitis optica.

Wang H, Wang K, Wang C, Xu F, Qiu W, Hu X.

J Clin Immunol. 2013 Apr;33(3):666-70. doi: 10.1007/s10875-012-9837-2. Epub 2012 Nov 21.

PMID:
23180362
12.

The clinical course of neuromyelitis optica (Devic's syndrome).

Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG.

Neurology. 1999 Sep 22;53(5):1107-14.

PMID:
10496275
13.

Two cases of benign neuromyelitis optica in patients with celiac disease.

Bergamaschi R, Jarius S, Robotti M, Pichiecchio A, Wildemann B, Meola G.

J Neurol. 2009 Dec;256(12):2097-9. doi: 10.1007/s00415-009-5288-y.

PMID:
21473007
14.

Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.

Ferreira TB, Barros PO, Teixeira B, Cassano T, Centurião N, Kasahara TM, Hygino J, Vasconcelos CC, Filho HA, Alvarenga R, Wing AC, Andrade RM, Andrade AF, Bento CA.

Brain Behav Immun. 2014 Oct;41:182-90. doi: 10.1016/j.bbi.2014.05.013. Epub 2014 Jun 2.

PMID:
24882215
15.

Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).

Jarius S, Wildemann B.

J Neurol Sci. 2015 Nov 15;358(1-2):419-21. doi: 10.1016/j.jns.2015.08.022. Epub 2015 Aug 15.

PMID:
26303625
16.

Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.

Uzawa A, Mori M, Hayakawa S, Masuda S, Nomura F, Kuwabara S.

BMC Neurol. 2010 Nov 11;10:113. doi: 10.1186/1471-2377-10-113.

17.

Devic's syndrome and primary APS: a new immunological overlap.

Squatrito D, Colagrande S, Emmi L.

Lupus. 2010 Oct;19(11):1337-9. doi: 10.1177/0961203310368968. Epub 2010 May 26.

PMID:
20504834
18.

Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.

Uzawa A, Mori M, Ito M, Uchida T, Hayakawa S, Masuda S, Kuwabara S.

J Neurol. 2009 Dec;256(12):2082-4. doi: 10.1007/s00415-009-5274-4.

PMID:
19655191
19.

[Devic's neuromyelitis optica: diagnosis after 10 years of bilateral severe relapsing optic neuritis].

Déral-Stéphant V, Roux-Lelièvre C, Vignal R, Stéphant E, Faivre A, Alla P.

J Fr Ophtalmol. 2008 Sep;31(7):705-9. French.

20.

[Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].

Jordan B, Eger K, Kornhuber ME, Zierz S.

Fortschr Neurol Psychiatr. 2008 Jan;76(1):21-7. doi: 10.1055/s-2007-993032. Review. German.

PMID:
18189220

Supplemental Content

Support Center